Related Experiment Video
Updated: May 28, 2026
07:45
Tear-Derived Exosomal miR-15a as New Diagnostic Tool for Diabetic Retinopathy
Published on: December 30, 2025
MicroRNAs in hepatic pathophysiology in diabetes
Kirandeep Kaur1, Himanshi Bhatia, Malabika Datta
1Kirandeep Kaur, Himanshi Bhatia, Malabika Datta, Institute of Genomics and Integrative Biology, CSIR, Mall Road, Delhi-110 007, India.
World Journal of Diabetes
|October 21, 2011
Summary
MicroRNAs (miRNAs) are small RNA molecules regulating bodily processes. This study explores how specific miRNAs contribute to altered liver function in diabetes, a complex metabolic disease.
Area of Science:
- Biochemistry
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) are small RNA molecules regulating gene expression.
- Diabetes mellitus is a complex metabolic disorder characterized by disrupted glucose homeostasis.
- The liver plays a crucial role in glucose metabolism, and its dysfunction is central to diabetes.
Purpose of the Study:
- To investigate the role of miRNAs in altered hepatic physiology during diabetes.
- To consolidate current knowledge on miRNAs implicated in the diabetic liver.
- To provide insights into the complex pathophysiology of diabetes.
Main Methods:
- Literature review of studies on miRNAs in diabetic liver.
- Analysis of reported miRNA functions in hepatic glucose metabolism.
- Synthesis of information on miRNA-mediated regulation in diabetic liver pathophysiology.
Main Results:
- Specific miRNAs have been identified as key regulators in the diabetic liver.
- These miRNAs influence hepatic glucose production and other metabolic functions.
- Altered miRNA expression contributes to the disease phenotype in diabetes.
Conclusions:
- miRNAs represent a significant regulatory layer in hepatic pathophysiology of diabetes.
- Understanding miRNA roles offers novel therapeutic targets for diabetes.
- Further research is needed to fully elucidate miRNA functions in the diabetic liver.
Related Concept Videos
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:21Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.